Related Experiment Video
Updated: Apr 17, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis
Andrea Lunardi1, Shohreh Varmeh1, Ming Chen1
1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Unlabelled:
The ETS family of transcription factors has been repeatedly implicated in tumorigenesis. In prostate cancer, ETS family members, such as ERG, ETV1, ETV4, and ETV5, are frequently overexpressed due to chromosomal translocations, but the molecular mechanisms by which they promote prostate tumorigenesis remain largely undefined. Here, we show that ETS family members, such as ERG and ETV1, directly repress the expression of the checkpoint kinase 1 (CHK1), a key DNA damage response cell-cycle regulator essential for the maintenance of genome integrity. Critically, we find that ERG expression correlates with CHK1 downregulation in human patients and demonstrate that Chk1 heterozygosity promotes the progression of high-grade prostatic intraepithelial neoplasia into prostatic invasive carcinoma in Pten(+) (/-) mice. Importantly, CHK1 downregulation sensitizes prostate tumor cells to etoposide but not to docetaxel treatment. Thus, we identify CHK1 as a key functional target of the ETS proto-oncogenic family with important therapeutic implications.
Significance:
Genetic translocation and aberrant expression of ETS family members is a common event in different types of human tumors. Here, we show that through the transcriptional repression of CHK1, ETS factors may favor DNA damage accumulation and consequent genetic instability in proliferating cells. Importantly, our findings provide a rationale for testing DNA replication inhibitor agents in ETS-positive TP53-proficient tumors.
Insights
ETS factors like ERG repress checkpoint kinase 1 (CHK1) in prostate cancer, promoting tumor growth. Downregulating CHK1 sensitizes tumors to etoposide, offering new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- ETS transcription factors are frequently overexpressed in prostate cancer due to chromosomal translocations.
- The precise mechanisms by which ETS factors drive prostate tumorigenesis are not fully understood.
Purpose of the Study:
- To investigate the role of ETS family members in regulating DNA damage response pathways in prostate cancer.
- To identify functional targets of ETS factors involved in prostate tumorigenesis.
Main Methods:
- Analysis of CHK1 expression in relation to ERG expression in human prostate cancer patients.
- Utilizing a Pten(+/-) mouse model to study the in vivo effects of Chk1 heterozygosity on prostate cancer progression.
- Evaluating the sensitivity of prostate tumor cells with downregulated CHK1 to etoposide and docetaxel treatments.
Main Results:
- ETS family members, including ERG and ETV1, were found to directly repress the expression of checkpoint kinase 1 (CHK1).
- ERG expression positively correlated with CHK1 downregulation in human prostate cancer.
- Chk1 heterozygosity accelerated the progression of prostatic intraepithelial neoplasia to invasive carcinoma in mice.
- CHK1 downregulation rendered prostate tumor cells sensitive to etoposide but not docetaxel.
Conclusions:
- ETS factors contribute to prostate tumorigenesis by transcriptionally repressing CHK1, a key regulator of DNA damage response and genome integrity.
- CHK1 downregulation by ETS factors may lead to DNA damage accumulation and genetic instability.
- These findings support the testing of DNA replication inhibitors in ETS-positive, TP53-proficient tumors.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

